Vaxcyte closes $1.15 billion public offering
Vaxcyte (PCVX) announced the closing of its $1.15 billion public offerings of common stock, pre-funded warrants, and convertible senior notes, including full exercise of underwriters’ options to purchase additional shares and convertible senior notes.